Litigation

Tamiflu Fraud Bilked $1.5 Billion from Government, Alleges Whistleblower

Lawsuit: Roche Pharma misrepresented flu drug’s ability to contain influenza pandemic

BALTIMORE – Drug company Hoffmann-La Roche (OTCMKTS – RHHBY) bilked U.S. federal and state governments out of $1.5 billion by misrepresenting clinical studies and falsely claiming that its well-known influenza medicine Tamiflu was effective at containing potential pandemics, according to a recently unsealed whistleblower lawsuit. 
Continue reading “Tamiflu Fraud Bilked $1.5 Billion from Government, Alleges Whistleblower”

Texas Hotels Willfully Blind to Sex Trafficking, Exploitation, Lawsuit Charges

Big-name hotel chains accused of profiting from sex trade, ignoring criminal activity

 

DALLAS – Three national hotel chains are accused in a federal lawsuit of being complicit in rampant sex trafficking at hotels across the U.S., including a North Texas woman who was victimized at various Dallas-area hotels since age 4. Continue reading “Texas Hotels Willfully Blind to Sex Trafficking, Exploitation, Lawsuit Charges”

Rick Meadow of Lanier Law Firm Gets Key Role in Cancer Lawsuits against J&J

Houston lawyer named to committee driving talcum powder litigation

HOUSTON – Acclaimed Houston trial lawyer Richard “Rick” Meadow of The Lanier Law Firm has been named to the Plaintiffs’ Executive Committee in the federal multi-district litigation against Johnson & Johnson over ovarian cancer claims involving the company’s talcum powder products.

Continue reading “Rick Meadow of Lanier Law Firm Gets Key Role in Cancer Lawsuits against J&J”

Pinnacle Hip Lawsuit

Dallas Jury Returns $1 Billion Plus Verdict in Defective DePuy/J&J Hip Implants Lawsuit

Attorney Mark Lanier: Third MDL bellwether trial sends strong message

DALLAS – A federal jury in Dallas has returned a combined verdict of more than $1 billion on behalf of six people who suffered serious medical complications caused by defective metal-on-metal hip implants made by Johnson & Johnson (NYSE: JNJ) and its subsidiary DePuy/J&J Orthopaedics Inc.

The verdict includes more than $30 million in actual damages for the six plaintiffs and more than $1 billion in punitive damages assessed against Johnson & Johnson and DePuy/J&J.

Continue reading “Dallas Jury Returns $1 Billion Plus Verdict in Defective DePuy/J&J Hip Implants Lawsuit”

EpiPen Maker Mylan Hit With Class-Action Lawsuit

Lawsuit seeks damages for Mylan’s unconscionable sales tactics

HOUSTON – A class-action lawsuit filed against pharmaceutical giant Mylan Inc. (NASDAQ: MYL) seeks damages for consumers victimized by the company’s cutthroat sales and marketing tactics related to controversial price increases for Mylan’s EpiPen injectors.

The lawsuit filed by The Lanier Law Firm and Sharp Law on behalf of consumers who have purchased EpiPen injectors charges that Mylan began a series of aggressive price increases shortly after it acquired the rights to sell the EpiPen in 2007. Mylan required consumers to purchase the EpiPen in pairs and raised the retail price from $57 in 2007 to more than $600 today, even though pharmaceutical industry sources estimate each injector can be produced for less than $30.

Continue reading “EpiPen Maker Mylan Hit With Class-Action Lawsuit”